According to the latest report by IMARC Group, the global hypodermic needles market size reached a value of US$ 2.48 Billion in 2021. It is projected to reach a value of US$ 3.86 Billion by 2027 exhibiting a CAGR of 7.20% during 2022-2027.
Hypodermic needles represent thin and hollow needles that are used with a syringe to inject substances into the body. They have a smooth and sharp surface that prevents and minimizes contamination during the inoculation of a sterile substrate. Hypodermic needles are manufactured using stainless-steel tubes via the tube drawing process.
Moreover, they are utilized to provide medications that cannot be ingested orally and also aid in extracting fluids from the body. Consequently, hypodermic needles find wide-ranging applications across the healthcare sector and in research processes requiring sterile conditions.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Market Size Value in 2021: | US$ 2.48 Billion |
Growth Rate: | CAGR of 7.20% from 2022 to 2027 |
Market Outlook: | 2022-2027 |
Important Attribute and highlights of the Report:
- Detailed analysis of the global market share
- Market Segmentation
- Historical, current, and projected size of the market in terms of volume and value
- Latest industry trends and developments
- Competitive Landscape
- Strategies of major players and product offerings
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/hypodermic-needles-market/requestsample
Hypodermic Needles Market Trends and Drivers:
The widespread product adoption by physicians, medical professionals, and paramedics for the intradermal delivery of liquids for emergencies, vaccinations, blood sample collections, etc., is primarily driving the hypodermic needles market. In line with this, the rising prevalence of chronic medical ailments, such as diabetes, cancer, cardiovascular disorders (CVDs), etc., is inflating the need for injectable drugs, which, in turn, is further stimulating the market growth.
Additionally, the growing utilization of hypodermic needles, on account of the sudden outbreak of the COVID-19 pandemic, is acting as another significant growth-inducing factor. Besides this, the implementation of various stringent regulations by government bodies across countries that mandate the use of safety needles to mitigate the risk of infections and prevent needle-stick injuries is also augmenting the global market.
Furthermore, the introduction of precision-engineered product variants by the leading manufacturers to enhance patient comfort in parenteral therapies and reduce penetration resistance is anticipated to fuel the hypodermic needles market over the forecasted period.
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
B. Braun Melsungen AG, Becton Dickinson and Company, Cardinal Health Inc., Connecticut Hypodermics Inc., EXELINT International Co., Hi-Tech Syringes, McKesson Corporation, Medline Industries LP, Nipro Corporation, Retractable Technologies Inc., Smiths Medical Inc. (ICU Medical Inc.) and Terumo Corporation.
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/hypodermic-needles-market
The report has segmented the market on the basis of region, product type, application and end user.
Breakup by Product Type:
- Safety Hypodermic Needles
- Non-Safety Hypodermic Needles
Breakup by Application:
- Drug Delivery
- Vaccination
- Blood Specimen Collection
Breakup by End User:
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Diabetic Patients
- Family Practices
- Psychiatrics
- Others
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.